Medindia

Febcid (20 mg) (Famotidine) Drug Price and Information

Famotidine (Febcid (20 mg)) is a histamine (H2-receptor antagonist), prescribed for ulcer. It works by decreasing the amount of stomach acid. The information provided on this page is intended to serve ...
Pharmabiz

FDA approves Johnson & Johnson-Merck's famotidine 20 mg for heartburn

Johnson & Johnson-Merck Consumer Pharmaceuticals Company has received the approval from the U.S. Food and Drug Administration (FDA) for Maximum Strength Pepcid AC (famotidine 20 mg) for ...
Business Wire

FRESENIUS KABI ISSUES VOLUNTARY NATIONWIDE RECALL OF THREE LOTS OF FAMOTIDINE INJECTION, USP, 20 MG PER 2 ML (10 MG PER ML), 2 ML FILL IN A 2 ML VIAL DUE TO OUT ...

Famotidine Injection is indicated in some hospitalized patients with pathological hypersecretory conditions or intractable ulcers, or as an alternative to the oral dosage forms for short term use in ...
EurekAlert!

Study finds unexpected results in acid suppression between two OTC heartburn treatments

OKLAHOMA CITY, OK, January 10, 2007 – In a new study, researchers have directly compared the early therapeutic response of drugs from widely-used classes of heartburn medications, omeprazole magnesium ...
Nasdaq

Dr. Reddy's Re-launches OTC Famotidine Tablets In U.S. - Quick Facts

(RTTNews) - Dr. Reddy's Laboratories Ltd. (DRREDDY, RDY) announced Tuesday the re-launch of over-the-counter or OTC Famotidine Tablets USP, 10 mg and 20 mg, in the U.S. market. OTC Famotidine Tablets ...
Nasdaq

Dr. Reddy’s announces the re-launch of over-the-counter Famotidine Tablets USP, 10 mg and 20 mg, store-brand equivalent of Pepcid AC® in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
USA Today

Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of ...

FOR IMMEDIATE RELEASE – Nov. 6,2025 – LAKE ZURICH, Ill.— Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies is ...
The Bakersfield Californian

Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of ...

Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies is voluntarily recalling three lots (numbers 6133156, 6133194, ...
Yahoo Finance

CORRECTING and REPLACING Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial ...

Three lots (numbers 6133156, 6133194, 6133388) of Famotidine Injection are being recalled in the U.S. by Fresenius Kabi. Three lots (numbers 6133156, 6133194, 6133388) of Famotidine Injection are ...
MarketWatch

CORRECTING and REPLACING: Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial ...

In the table of the release dated Nov 6, 2025, First Ship Date for Batch Number 6133388 should be 04/15/2025. FRESENIUS KABI ISSUES VOLUNTARY NATIONWIDE RECALL OF THREE LOTS OF FAMOTIDINE INJECTION, ...